Global Human Plasma-derived Hyperimmune Product Supply, Demand and Key Producers, 2023-2029

Global Human Plasma-derived Hyperimmune Product Supply, Demand and Key Producers, 2023-2029

The global Human Plasma-derived Hyperimmune Product market size is expected to reach $ 2866.8 million by 2029, rising at a market growth of 5.9% CAGR during the forecast period (2023-2029).

Hyperimmune globulin is similar to intravenous immunoglobulin (IVIG) except that it is prepared from the plasma of donors with high titers of antibody against a specific organism or antigen. Some agents against which hyperimmune globulins are available include hepatitis B, rabies, tetanus toxin, varicella-zoster, etc. Administration of hyperimmune globulin provides "passive" immunity to the patient against an agent. This is in contrast to vaccines that provide "active" immunity. However, vaccines take much longer to achieve that purpose while hyperimmune globulin provides instant "passive" short-lived immunity. Hyperimmune globulin may have serious side effects, thus usage is taken very seriously.

This report studies the global Human Plasma-derived Hyperimmune Product production, demand, key manufacturers, and key regions.

This report is a detailed and comprehensive analysis of the world market for Human Plasma-derived Hyperimmune Product, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Human Plasma-derived Hyperimmune Product that contribute to its increasing demand across many markets.

Highlights and key features of the study

Global Human Plasma-derived Hyperimmune Product total production and demand, 2018-2029, (K Units)

Global Human Plasma-derived Hyperimmune Product total production value, 2018-2029, (USD Million)

Global Human Plasma-derived Hyperimmune Product production by region & country, production, value, CAGR, 2018-2029, (USD Million) & (K Units)

Global Human Plasma-derived Hyperimmune Product consumption by region & country, CAGR, 2018-2029 & (K Units)

U.S. VS China: Human Plasma-derived Hyperimmune Product domestic production, consumption, key domestic manufacturers and share

Global Human Plasma-derived Hyperimmune Product production by manufacturer, production, price, value and market share 2018-2023, (USD Million) & (K Units)

Global Human Plasma-derived Hyperimmune Product production by Type, production, value, CAGR, 2018-2029, (USD Million) & (K Units)

Global Human Plasma-derived Hyperimmune Product production by Application production, value, CAGR, 2018-2029, (USD Million) & (K Units)

This reports profiles key players in the global Human Plasma-derived Hyperimmune Product market based on the following parameters – company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include CSL Behring, Grifols, Biotest, Kedrion, CBPO, Emergent (Cangene), Kamada, CNBG and Hualan Bio, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Human Plasma-derived Hyperimmune Product market

Detailed Segmentation:

Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.

Global Human Plasma-derived Hyperimmune Product Market, By Region:
United States
China
Europe
Japan
South Korea
ASEAN
India
Rest of World

Global Human Plasma-derived Hyperimmune Product Market, Segmentation by Type
Hepatitis B Immunoglobulins
Rabies Immunoglobulins
Tetanus Immunoglobulins
Rho(D) Immunoglobulins
Other

Global Human Plasma-derived Hyperimmune Product Market, Segmentation by Application
Government Institution
Private Sector
Others

Companies Profiled:
CSL Behring
Grifols
Biotest
Kedrion
CBPO
Emergent (Cangene)
Kamada
CNBG
Hualan Bio
Shanghai RAAS
Sichuan Yuanda Shuyang
ADMA Biologics

Key Questions Answered

1. How big is the global Human Plasma-derived Hyperimmune Product market?

2. What is the demand of the global Human Plasma-derived Hyperimmune Product market?

3. What is the year over year growth of the global Human Plasma-derived Hyperimmune Product market?

4. What is the production and production value of the global Human Plasma-derived Hyperimmune Product market?

5. Who are the key producers in the global Human Plasma-derived Hyperimmune Product market?

6. What are the growth factors driving the market demand?